Evidence map›Paper›PMID 42640877›Full record

ArticlePLoS biology2026

Retracing the origin and evolution of a cryptic antimicrobial peptide within mammalian lactoferrin.

Titas Sil, Caitlin H Kowalski, Sierra Scamfer, Natalie Copeland, Matthew F Barber

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Titas SilInstitute of Ecology and Evolution, University of Oregon, Eugene, Oregon, United States of America.
Caitlin H KowalskiInstitute of Ecology and Evolution, University of Oregon, Eugene, Oregon, United States of America.
Sierra ScamferDepartment of Biology, University of Oregon, Eugene, Oregon, United States of America.
Natalie CopelandDepartment of Biology, University of Oregon, Eugene, Oregon, United States of America.ORCID https://orcid.org/0009-0003-0229-9827
Matthew F BarberInstitute of Ecology and Evolution, University of Oregon, Eugene, Oregon, United States of America.ORCID https://orcid.org/0000-0003-2008-2165

Funding

MOLECULAR BIOLOGY AND BIOPHYSICST32GM007759 · NIGMS · UNIVERSITY OF OREGON · PI NOLEN, BRADLEY J · 1985 to 2021
$8.5M
Molecular mechanisms of evolution at the host-microbe interfaceR35GM133652 · NIGMS · UNIVERSITY OF OREGON · PI BARBER, MATTHEW FREDERICK · 2019 to 2023
$1.8M
Mechanisms of evolution at the host-pathogen interfaceR35GM158176 · NIGMS · UNIVERSITY OF OREGON · PI Matthew Frederick Barber · 2025 to 2026
$805k
Host range determinants of bacterial exfoliative toxinsR21AI173839 · NIAID · UNIVERSITY OF OREGON · PI BARBER, MATTHEW FREDERICK · 2023 to 2024
$406k
NIAID NIH HHS R21 AI173839NIGMS NIH HHS R35 GM133652NIGMS NIH HHS R35 GM158176NIGMS NIH HHS T32 GM007759
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) constitute key components of innate immunity across the tree of life. Canonical AMPs are typically translated as small proteins and secreted from host cells to act against microbes. However, cryptic AMP-like domains are also embedded within diverse proteins not classically associated with antimicrobial function. How such embedded AMPs first emerge and diversify remains unclear. Here we retrace the origin and evolution of the abundant mammalian protein lactoferrin and its embedded AMP, lactoferricin. By resurrecting extinct lactoferrin ancestors dating back to the earliest mammals, we identify an enrichment of cationic and hydrophobic amino acids in the lactoferricin domain over time. These changes enabled ancient lactoferricin to first rupture bacterial membranes, an activity that was later enhanced in extant mammals conferring potent bactericidal activity. In addition, we find that natural selection within the lactoferricin domain has continued to modulate antimicrobial activity on recent evolutionary timescales. In particular, we pinpoint a single rapidly evolving site in lactoferricin among great apes that significantly enhances antimicrobial potency against major pathogenic bacteria. Together, our study illustrates how novel immune protein functions can arise, evolve, and diversify to strengthen host defense against microbial pathogens.

Indexed as

Antimicrobial Cationic PeptidesAntimicrobial PeptidesEvolution, MolecularLactoferrinAmino Acid SequenceAnimalsHumansMammalsPhylogenyProtein DomainsAntimicrobial Cationic PeptidesAntimicrobial Peptideslactoferricin BLactoferrin

Identifiers

PMID42640877
PMCPMC13505947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.